Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.2K Buy
238
+116
+95% +$2.69K ﹤0.01% 1222
2025
Q4
$2.84K Sell
122
-25
-17% -$603 ﹤0.01% 943
2025
Q3
$4.16K Buy
147
+48
+48% +$1.27K ﹤0.01% 915
2025
Q2
$2.18K Buy
+99
New +$2.16K ﹤0.01% 984
2025
Q1
Sell
-45
Closed -$1.29K 1424
2024
Q4
$1.29K Sell
45
-13
-22% -$389 ﹤0.01% 1051
2024
Q3
$1.72K Sell
58
-5
-8% -$155 ﹤0.01% 999
2024
Q2
$2.12K Buy
+63
New +$2.17K ﹤0.01% 949
2022
Q3
Sell
-60
Closed -$2K 896
2022
Q2
$2K Buy
+60
New +$1.75K ﹤0.01% 828
2022
Q1
Sell
-40
Closed -$1K 966
2021
Q4
$1K Buy
+40
New +$1.42K ﹤0.01% 876
2021
Q3
Sell
-135
Closed -$4K 559
2021
Q2
$4K Buy
+135
New +$4.68K ﹤0.01% 799

Other funds holding GNTX

CVA Family Office's GNTX Position: Q1 2026 in Review

CVA Family Office increased its Gentex (GNTX) stake by 95% in Q1 2026, buying an estimated $2.69K and bringing the position to 238 shares worth $5.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

CVA Family Office first reported a position in GNTX in Q2 2021 and has held it in 10 quarters since. 501 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

  • CVA Family Office held 238 shares of Gentex worth $5.2K as of Q1 2026.
  • CVA Family Office bought 116 Gentex shares in Q1 2026, an estimated $2.69K.
  • Gentex made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1222 holding.
  • CVA Family Office first reported a position in Gentex in Q2 2021 and has held it in 10 quarters since.
  • 501 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.